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KEYFINDINGS

Narrower provider networks offered on the health insurance exchanges are more likely to exclude oncologists associated with
high-quality National Cancer Institute (NCI)-Designated Cancer Centers. These findings suggest that narrower oncology
networks, while offering lower premiums, may involve a tradeoff between cost and quality of cancer care.
THE QUESTION

THE FINDINGS

To reduce the cost of insurance plans, health insurers are increasingly
marketing plans that restrict access to providers (both hospitals and
physicians). These narrow provider networks allow insurers to offer pricecompetitive plans, often through lower reimbursement rates or selective
contracting with providers treating lower-cost patients. Whether narrow
networks limit access to high quality providers is not known.

Of 407 markets (rating areas) in the country, 51 had an NCI-Designated
Center; 27 of them had an NCCN center. The supply of oncologists was
greater in markets with an NCI-Designated Cancer than other markets
(13.7 vs. 8.8 per 100,000 residents).

NCI-Designated Cancer Centers, and a subset of them identified as
National Comprehensive Cancer Network (NCCN) Cancer Centers, are
recognized for their scientific leadership, cutting-edge medical technology,
and lower mortality rates among severely ill patients. These prestigious
cancer centers are more likely to attract patients requiring costly care, and
insurers have a strong incentive to exclude oncologists associated with
NCI or NCCN Cancer Centers from narrow networks. In this study, the
authors assess the extent to which narrow networks systematically exclude
NCI or NCCN-affiliated oncologists, and address the implications for
whether narrow networks require a tradeoff between cost and quality.

The authors identified 248 provider networks in these 51 markets.
Networks in these markets were narrower than in other markets, covering
NETWORK BREADTH AND RELATIVE INCLUSION OF
ONCOLOGISTS AFFILIATED WITH NATIONAL CANCER
INSTITUTE (NCI)–DESIGNATED CANCER CENTERS

Source: Yasaitis et al., Journal of Clinical Oncology.
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an average of 39.4% of area oncologists versus 49.9% in other markets.
Despite this narrowness, the average number of covered oncologists
per 100,000 residents was higher than in markets containing a NCIDesignated Center than other markets (4.5 vs. 3.8). However, 33 of
248 networks did not contain a single physician affiliated with an NCI
center; these networks were narrower (covering only 14.1% of local
oncologists) than networks including at least one NCI-affiliated physician
(covering 42.3% of local oncologists). The figure on the front shows that
oncology network breadth was associated with inclusion of NCI-affiliated
oncologists, indicating that narrower networks are more likely to exclude
these physicians.

THE IMPLICATIONS
This is the first study to demonstrate a correlation between narrow
networks and exclusion of NCI- and NCCN-affiliated providers. These
hospitals are recognized for their high-quality cancer care, education, and
research programs. Thus, this finding suggests that narrow networks may
not just offer fewer providers, but that the limited number of providers
included may not offer the same quality care as those who have been
excluded. This highlights a critical tradeoff that consumers face when
purchasing a narrow network plan: they may benefit from the lower
premiums charged by narrow network plans, but they may face reduced
access to higher-quality providers in their market.
These findings are relevant to replacement proposals for the Affordable
Care Act, that emphasize shoppable insurance plans for consumers. As
consumers seek to learn about providers and coverage included in their
plans, accurate information about these providers is essential. In 2016, the
Centers for Medicare & Medicaid Services enacted rules for publishing
user-friendly provider directories that include a provider’s location,
contact information, specialty, medical group, and any hospital affiliations.
This study’s findings indicate that inclusion of quality indicators in these
provider directories – such as NCI or NCCN affiliation for cancer
providers – may prove useful to consumers shopping health plans.
The question this study raises, but cannot answer, is whether or not
insurers specifically exclude physicians at higher rates because of their
NCI or NCCN designation, or whether exclusion results from an
additional correlated factor. For example, group practice size may be
associated with market power and pricing, and may be a factor in an
insurer’s choice to exclude a provider. Furthermore, the data do not
identify differences in actual care quality between NCI and non-NCI
centers. Future research should examine the relationship between narrow
networks and cancer care outcomes.

ResearchBRIEF

THE STUDY
The authors used a registry of all office-based physicians to identify
practicing physicians with a specialty of hematology/oncology or
radiation oncology, and identified oncologists affiliated with one of the
69 NCI-Designated Cancer Centers, and the subset that were NCCN
Cancer Centers. They examined provider networks offered on the 2014
individual health insurance exchanges using a previously integrated
dataset, and identified 51 markets (rating areas) containing at least one
NCI-Designated Cancer Centers.
The breadth of each network was calculated as the number of oncologists
included in the network divided by the total number of oncologists
practicing in that market. They measured a network’s likelihood of
including high-quality oncologists within each market by the proportion
with NCI (or NCCN) affiliation among the market’s oncologists included
in the network, divided by the proportion of those with NCI (or NCCN)
affiliation among the market’s oncologists excluded from the network.
Values greater than one indicate relative inclusion—and values less
than one relative exclusion. Then, the authors assessed the relationship
between network breadth and the inclusion measure for all networks
offered in any market containing an NCI-Designated Cancer Center.
They also ran separate analyses for NCCN centers, but the results did
not differ for this subset of cancer centers.
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